aluates Reports

$ 0.0

Automative

Global Fibromyalgia Therapeutics Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-2D13946

Global Fibromyalgia Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Fibromyalgia Therapeutics Market Research Report 2025

Code: QYRE-Auto-2D13946

Report

June 2025

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eli Lilly

Actavis

Merck Sharp and Dohme

Innovative Med Concepts

MEDA Co.

Meiji Seika

Switch Biotech

Theravance Inc

Zynerba Pharmaceuticals

Tonix Pharmaceuticals Holding Corp. (TNXP)

Forest Pharmaceuticals, Inc.

Boehringer Ingelheim GmbH

Pierre Fabre Mdicament

Pfizer Inc

Daiichi Sankyo

Fibromyalgia Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Fibromyalgia Therapeutics Market

The global market for Fibromyalgia Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Fibromyalgia Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibromyalgia Therapeutics.

The Fibromyalgia Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fibromyalgia Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Fibromyalgia Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Fibromyalgia Therapeutics Market Report

Report Metric	Details
Report Name	Fibromyalgia Therapeutics Market
CAGR	5%
Segment by Type	Cymbalta (Duloxetine) Savella (Milnacipran) Lyrica (Pregabalin) Pancuronium Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Eli Lilly, Actavis, Merck Sharp and Dohme, Daiichi Sankyo, Innovative Med Concepts, Meda, Meiji Seika, Switch Biotech, Theravance, Zynerba Pharmaceuticals, Tonix Pharmaceuticals Holding Corp. (TNXP), Forest Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Pierre Fabre Mdicament
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fibromyalgia Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Fibromyalgia Therapeutics Market report?

Ans: The main players in the Fibromyalgia Therapeutics Market are Pfizer, Eli Lilly, Actavis, Merck Sharp and Dohme, Daiichi Sankyo, Innovative Med Concepts, Meda, Meiji Seika, Switch Biotech, Theravance, Zynerba Pharmaceuticals, Tonix Pharmaceuticals Holding Corp. (TNXP), Forest Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Pierre Fabre Mdicament

What are the Application segmentation covered in the Fibromyalgia Therapeutics Market report?

Ans: The Applications covered in the Fibromyalgia Therapeutics Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Fibromyalgia Therapeutics Market report?

Ans: The Types covered in the Fibromyalgia Therapeutics Market report are Cymbalta (Duloxetine), Savella (Milnacipran), Lyrica (Pregabalin), Pancuronium, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Fibromyalgia Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cymbalta (Duloxetine)

1.2.3 Savella (Milnacipran)

1.2.4 Lyrica (Pregabalin)

1.2.5 Pancuronium

1.2.6 Others

1.3 Market by Application

1.3.1 Global Fibromyalgia Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Fibromyalgia Therapeutics Market Perspective (2020-2031)

2.2 Global Fibromyalgia Therapeutics Growth Trends by Region

2.2.1 Global Fibromyalgia Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Fibromyalgia Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Fibromyalgia Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Fibromyalgia Therapeutics Market Dynamics

2.3.1 Fibromyalgia Therapeutics Industry Trends

2.3.2 Fibromyalgia Therapeutics Market Drivers

2.3.3 Fibromyalgia Therapeutics Market Challenges

2.3.4 Fibromyalgia Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Fibromyalgia Therapeutics Players by Revenue

3.1.1 Global Top Fibromyalgia Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Fibromyalgia Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Fibromyalgia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Fibromyalgia Therapeutics Revenue

3.4 Global Fibromyalgia Therapeutics Market Concentration Ratio

3.4.1 Global Fibromyalgia Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Therapeutics Revenue in 2024

3.5 Global Key Players of Fibromyalgia Therapeutics Head office and Area Served

3.6 Global Key Players of Fibromyalgia Therapeutics, Product and Application

3.7 Global Key Players of Fibromyalgia Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Fibromyalgia Therapeutics Breakdown Data by Type

4.1 Global Fibromyalgia Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Fibromyalgia Therapeutics Forecasted Market Size by Type (2026-2031)

5 Fibromyalgia Therapeutics Breakdown Data by Application

5.1 Global Fibromyalgia Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Fibromyalgia Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Fibromyalgia Therapeutics Market Size (2020-2031)

6.2 North America Fibromyalgia Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Fibromyalgia Therapeutics Market Size by Country (2020-2025)

6.4 North America Fibromyalgia Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Fibromyalgia Therapeutics Market Size (2020-2031)

7.2 Europe Fibromyalgia Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Fibromyalgia Therapeutics Market Size by Country (2020-2025)

7.4 Europe Fibromyalgia Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Fibromyalgia Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Fibromyalgia Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Fibromyalgia Therapeutics Market Size (2020-2031)

9.2 Latin America Fibromyalgia Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Fibromyalgia Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Fibromyalgia Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Fibromyalgia Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Fibromyalgia Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Fibromyalgia Therapeutics Introduction

11.1.4 Pfizer Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Eli Lilly

11.2.1 Eli Lilly Company Details

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Fibromyalgia Therapeutics Introduction

11.2.4 Eli Lilly Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.2.5 Eli Lilly Recent Development

11.3 Actavis

11.3.1 Actavis Company Details

11.3.2 Actavis Business Overview

11.3.3 Actavis Fibromyalgia Therapeutics Introduction

11.3.4 Actavis Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.3.5 Actavis Recent Development

11.4 Merck Sharp and Dohme

11.4.1 Merck Sharp and Dohme Company Details

11.4.2 Merck Sharp and Dohme Business Overview

11.4.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Introduction

11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.4.5 Merck Sharp and Dohme Recent Development

11.5 Daiichi Sankyo

11.5.1 Daiichi Sankyo Company Details

11.5.2 Daiichi Sankyo Business Overview

11.5.3 Daiichi Sankyo Fibromyalgia Therapeutics Introduction

11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.5.5 Daiichi Sankyo Recent Development

11.6 Innovative Med Concepts

11.6.1 Innovative Med Concepts Company Details

11.6.2 Innovative Med Concepts Business Overview

11.6.3 Innovative Med Concepts Fibromyalgia Therapeutics Introduction

11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.6.5 Innovative Med Concepts Recent Development

11.7 Meda

11.7.1 Meda Company Details

11.7.2 Meda Business Overview

11.7.3 Meda Fibromyalgia Therapeutics Introduction

11.7.4 Meda Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.7.5 Meda Recent Development

11.8 Meiji Seika

11.8.1 Meiji Seika Company Details

11.8.2 Meiji Seika Business Overview

11.8.3 Meiji Seika Fibromyalgia Therapeutics Introduction

11.8.4 Meiji Seika Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.8.5 Meiji Seika Recent Development

11.9 Switch Biotech

11.9.1 Switch Biotech Company Details

11.9.2 Switch Biotech Business Overview

11.9.3 Switch Biotech Fibromyalgia Therapeutics Introduction

11.9.4 Switch Biotech Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.9.5 Switch Biotech Recent Development

11.10 Theravance

11.10.1 Theravance Company Details

11.10.2 Theravance Business Overview

11.10.3 Theravance Fibromyalgia Therapeutics Introduction

11.10.4 Theravance Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.10.5 Theravance Recent Development

11.11 Zynerba Pharmaceuticals

11.11.1 Zynerba Pharmaceuticals Company Details

11.11.2 Zynerba Pharmaceuticals Business Overview

11.11.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Introduction

11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.11.5 Zynerba Pharmaceuticals Recent Development

11.12 Tonix Pharmaceuticals Holding Corp. (TNXP)

11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details

11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview

11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Introduction

11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development

11.13 Daiichi Sankyo

11.13.1 Daiichi Sankyo Company Details

11.13.2 Daiichi Sankyo Business Overview

11.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Introduction

11.13.4 Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.13.5 Daiichi Sankyo Recent Development

11.14 Forest Pharmaceuticals, Inc.

11.14.1 Forest Pharmaceuticals, Inc. Company Details

11.14.2 Forest Pharmaceuticals, Inc. Business Overview

11.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Introduction

11.14.4 Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.14.5 Forest Pharmaceuticals, Inc. Recent Development

11.15 Boehringer Ingelheim GmbH

11.15.1 Boehringer Ingelheim GmbH Company Details

11.15.2 Boehringer Ingelheim GmbH Business Overview

11.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Introduction

11.15.4 Boehringer Ingelheim GmbH Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.15.5 Boehringer Ingelheim GmbH Recent Development

11.16 Pierre Fabre Mdicament

11.16.1 Pierre Fabre Mdicament Company Details

11.16.2 Pierre Fabre Mdicament Business Overview

11.16.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Introduction

11.16.4 Pierre Fabre Mdicament Revenue in Fibromyalgia Therapeutics Business (2020-2025)

11.16.5 Pierre Fabre Mdicament Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Eli Lilly

Actavis

Merck Sharp and Dohme

Innovative Med Concepts

MEDA Co.

Meiji Seika

Switch Biotech

Theravance Inc

Zynerba Pharmaceuticals

Tonix Pharmaceuticals Holding Corp. (TNXP)

Forest Pharmaceuticals, Inc.

Boehringer Ingelheim GmbH

Pierre Fabre Mdicament

Pfizer Inc

Daiichi Sankyo

List of Tables

Table 1. Global Fibromyalgia Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cymbalta (Duloxetine)

Table 3. Key Players of Savella (Milnacipran)

Table 4. Key Players of Lyrica (Pregabalin)

Table 5. Key Players of Pancuronium

Table 6. Key Players of Others

Table 7. Global Fibromyalgia Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Fibromyalgia Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Fibromyalgia Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Fibromyalgia Therapeutics Market Share by Region (2020-2025)

Table 11. Global Fibromyalgia Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Fibromyalgia Therapeutics Market Share by Region (2026-2031)

Table 13. Fibromyalgia Therapeutics Market Trends

Table 14. Fibromyalgia Therapeutics Market Drivers

Table 15. Fibromyalgia Therapeutics Market Challenges

Table 16. Fibromyalgia Therapeutics Market Restraints

Table 17. Global Fibromyalgia Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Fibromyalgia Therapeutics Market Share by Players (2020-2025)

Table 19. Global Top Fibromyalgia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Therapeutics as of 2024)

Table 20. Ranking of Global Top Fibromyalgia Therapeutics Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Fibromyalgia Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Fibromyalgia Therapeutics, Headquarters and Area Served

Table 23. Global Key Players of Fibromyalgia Therapeutics, Product and Application

Table 24. Global Key Players of Fibromyalgia Therapeutics, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Fibromyalgia Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Fibromyalgia Therapeutics Revenue Market Share by Type (2020-2025)

Table 28. Global Fibromyalgia Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Fibromyalgia Therapeutics Revenue Market Share by Type (2026-2031)

Table 30. Global Fibromyalgia Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Fibromyalgia Therapeutics Revenue Market Share by Application (2020-2025)

Table 32. Global Fibromyalgia Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Fibromyalgia Therapeutics Revenue Market Share by Application (2026-2031)

Table 34. North America Fibromyalgia Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Fibromyalgia Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Fibromyalgia Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Fibromyalgia Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Fibromyalgia Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Fibromyalgia Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Fibromyalgia Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Fibromyalgia Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Fibromyalgia Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Fibromyalgia Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Fibromyalgia Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 49. Pfizer Company Details

Table 50. Pfizer Business Overview

Table 51. Pfizer Fibromyalgia Therapeutics Product

Table 52. Pfizer Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 53. Pfizer Recent Development

Table 54. Eli Lilly Company Details

Table 55. Eli Lilly Business Overview

Table 56. Eli Lilly Fibromyalgia Therapeutics Product

Table 57. Eli Lilly Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 58. Eli Lilly Recent Development

Table 59. Actavis Company Details

Table 60. Actavis Business Overview

Table 61. Actavis Fibromyalgia Therapeutics Product

Table 62. Actavis Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 63. Actavis Recent Development

Table 64. Merck Sharp and Dohme Company Details

Table 65. Merck Sharp and Dohme Business Overview

Table 66. Merck Sharp and Dohme Fibromyalgia Therapeutics Product

Table 67. Merck Sharp and Dohme Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 68. Merck Sharp and Dohme Recent Development

Table 69. Daiichi Sankyo Company Details

Table 70. Daiichi Sankyo Business Overview

Table 71. Daiichi Sankyo Fibromyalgia Therapeutics Product

Table 72. Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 73. Daiichi Sankyo Recent Development

Table 74. Innovative Med Concepts Company Details

Table 75. Innovative Med Concepts Business Overview

Table 76. Innovative Med Concepts Fibromyalgia Therapeutics Product

Table 77. Innovative Med Concepts Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 78. Innovative Med Concepts Recent Development

Table 79. Meda Company Details

Table 80. Meda Business Overview

Table 81. Meda Fibromyalgia Therapeutics Product

Table 82. Meda Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 83. Meda Recent Development

Table 84. Meiji Seika Company Details

Table 85. Meiji Seika Business Overview

Table 86. Meiji Seika Fibromyalgia Therapeutics Product

Table 87. Meiji Seika Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 88. Meiji Seika Recent Development

Table 89. Switch Biotech Company Details

Table 90. Switch Biotech Business Overview

Table 91. Switch Biotech Fibromyalgia Therapeutics Product

Table 92. Switch Biotech Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 93. Switch Biotech Recent Development

Table 94. Theravance Company Details

Table 95. Theravance Business Overview

Table 96. Theravance Fibromyalgia Therapeutics Product

Table 97. Theravance Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 98. Theravance Recent Development

Table 99. Zynerba Pharmaceuticals Company Details

Table 100. Zynerba Pharmaceuticals Business Overview

Table 101. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Product

Table 102. Zynerba Pharmaceuticals Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 103. Zynerba Pharmaceuticals Recent Development

Table 104. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details

Table 105. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview

Table 106. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Product

Table 107. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 108. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development

Table 109. Daiichi Sankyo Company Details

Table 110. Daiichi Sankyo Business Overview

Table 111. Daiichi Sankyo Fibromyalgia Therapeutics Product

Table 112. Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 113. Daiichi Sankyo Recent Development

Table 114. Forest Pharmaceuticals, Inc. Company Details

Table 115. Forest Pharmaceuticals, Inc. Business Overview

Table 116. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Product

Table 117. Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 118. Forest Pharmaceuticals, Inc. Recent Development

Table 119. Boehringer Ingelheim GmbH Company Details

Table 120. Boehringer Ingelheim GmbH Business Overview

Table 121. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Product

Table 122. Boehringer Ingelheim GmbH Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 123. Boehringer Ingelheim GmbH Recent Development

Table 124. Pierre Fabre Mdicament Company Details

Table 125. Pierre Fabre Mdicament Business Overview

Table 126. Pierre Fabre Mdicament Fibromyalgia Therapeutics Product

Table 127. Pierre Fabre Mdicament Revenue in Fibromyalgia Therapeutics Business (2020-2025) & (US$ Million)

Table 128. Pierre Fabre Mdicament Recent Development

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

Table 132. Authors List of This Report

List of Figures

Figure 1. Fibromyalgia Therapeutics Picture

Figure 2. Global Fibromyalgia Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Fibromyalgia Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Cymbalta (Duloxetine) Features

Figure 5. Savella (Milnacipran) Features

Figure 6. Lyrica (Pregabalin) Features

Figure 7. Pancuronium Features

Figure 8. Others Features

Figure 9. Global Fibromyalgia Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Fibromyalgia Therapeutics Market Share by Application: 2024 VS 2031

Figure 11. Hospital Case Studies

Figure 12. Clinic Case Studies

Figure 13. Others Case Studies

Figure 14. Fibromyalgia Therapeutics Report Years Considered

Figure 15. Global Fibromyalgia Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Fibromyalgia Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Fibromyalgia Therapeutics Market Share by Region: 2024 VS 2031

Figure 18. Global Fibromyalgia Therapeutics Market Share by Players in 2024

Figure 19. Global Top Fibromyalgia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Therapeutics as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Fibromyalgia Therapeutics Revenue in 2024

Figure 21. North America Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Fibromyalgia Therapeutics Market Share by Country (2020-2031)

Figure 23. United States Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Fibromyalgia Therapeutics Market Share by Country (2020-2031)

Figure 27. Germany Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Fibromyalgia Therapeutics Market Share by Region (2020-2031)

Figure 35. China Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Fibromyalgia Therapeutics Market Share by Country (2020-2031)

Figure 43. Mexico Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Fibromyalgia Therapeutics Market Share by Country (2020-2031)

Figure 47. Turkey Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Fibromyalgia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Pfizer Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 51. Eli Lilly Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 52. Actavis Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 53. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 54. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 55. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 56. Meda Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 57. Meiji Seika Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 58. Switch Biotech Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 59. Theravance Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 60. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 61. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 62. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 63. Forest Pharmaceuticals, Inc. Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 64. Boehringer Ingelheim GmbH Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 65. Pierre Fabre Mdicament Revenue Growth Rate in Fibromyalgia Therapeutics Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Fibromyalgia Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medications for Fibromyalgia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibromyalgia Antidepressant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pain Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Idiopathic Pulmonary Fibrosis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Arthritis Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibrinolytic Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibrate Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatology Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fibrocystic Breasts Diagnostics and Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Back and Spine Pain Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Autoimmune Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neck Pain Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Migraine Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Musculoskeletal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions